benign breast lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Pathologically confirmed benign breast lesion by ultrasound-guided core needle biopsy; 2.Received ultrasound-guided thermal ablation therapy; 3.Maximum diameter of the lesion =18 years; 5.Complete preoperative, intraoperative, and postoperative follow-up data (including ultrasound images, pathology reports, complication records, etc.);
Exclusion criteria
Exclusion criteria: 1.Pathologically confirmed malignant or borderline tumor; 2.Pregnant or lactating women; 3.Severe coagulation dysfunction; 4.Prior surgery at the same site; 5.Severe systemic disease; 6.Psychiatric disorder or cognitive impairment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lesion volume reduction rate 12 months after surgery;Treatment efficacy 12 months after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety (incidence of complications, grading of complication severity, correlation of complications with influencing factors);VRR at different follow-up time points;Complete disappearance rate of lesions;Retreatment rate;Symptom improvement; | — |
Countries
China
Contacts
Beijing Friendship Hospital ,Capital Medical University